Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Russo
    Russo
  3. Scardino
    Scardino
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Vickers
    Vickers
  7. D'Angelica
    D'Angelica
  8. Reuter
    Reuter
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (1790)
  2. Department of Medicine (1114)
  3. Urology (1072)
  4. Population Sciences Research Program (708)
  5. Solid Tumor Oncology Division (687)
  6. Survivorship Research (625)
  7. Sloan Kettering Institute Faculty (608)
  8. Epidemiology and Biostatistics (531)
  9. GSK Faculty (463)
  10. Radiology, Department of (436)
Search Within
Formats
  1. Journal Article (3611)
  2. Meeting Abstract (854)
  3. Editorial (87)
  4. Correspondence (65)
  5. Review (55)
  6. Guidelines (45)
  7. Conference Paper (26)
  8. Research Letter (15)
  9. Book Section (5)
  10. Miscellaneous (2)
Groups
  1. Surgery (1790)
  2. Department of Medicine (1114)
  3. Urology (1072)
  4. Population Sciences Research Program (708)
  5. Solid Tumor Oncology Division (687)
  6. Survivorship Research (625)

More Groups

People
  1. Harry Herr (261)
  2. Paul Russo (179)
  3. Andrew Vickers (178)
  4. Peter Scardino (171)
  5. James Eastham (152)
  6. William Jarnagin (142)

More People

Years
  1. 2022 (127)
  2. 2021 (232)
  3. 2020 (264)
  4. 2019 (224)
  5. 2018 (204)
  6. 2017 (230)

More Years

Publications
  1. Journal of Urology (709)
  2. European Urology (471)
  3. Urology (365)
  4. Lancet Oncology (323)
  5. Journal of the American College of Surgeons (319)
  6. Journal of Molecular Diagnostics (213)

More Publications

Results (4765)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: A multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial
    Journal Article

    Pagel, J. M.; Soumerai, J. D.; Reddy, N.; Jagadeesh, D.; Stathis, A.; Asch, A.; Salman, H.; Kenkre, V. P.; Iasonos, A.; Llorin-Sangalang, J.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: A single-arm, multicentre, phase 2 study
    Journal Article

    Budde, L. E.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: A phase 2b, multicentre study
    Journal Article

    Ehdaie, B.; Tempany, C. M.; Holland, F.; Sjoberg, D. D.; Kibel, A. S.; Trinh, Q. D.; Durack, J. C.; Akin, O.; Vickers, A. J.; Scardino, P. T.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): Long-term follow-up results from an open-label, randomised, phase 3 trial
    Journal Article

    Motzer, R. J.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Shah, A. Y.; Suárez, C.; Hamzaj, A.; Porta, C.; Hocking, C. M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Association of family history of cancer with clinical and pathological outcomes for prostate cancer patients on active surveillance
    Journal Article

    Jibara, G. A.; Perera, M.; Vertosick, E. A.; Sjoberg, D. D.; Vickers, A.; Scardino, P. T.; Eastham, J. A.; Laudone, V. P.; Touijer, K.; Lin, X.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Oncologic outcomes of total length Gleason pattern 4 on biopsy in men with grade group 2 prostate cancer
    Journal Article

    Perera, M.; Assel, M. J.; Benfante, N. E.; Vickers, A. J.; Reuter, V. E.; Carlsson, S.; Laudone, V.; Touijer, K. A.; Eastham, J. A.; Scardino, P. T.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Microwave ablation versus stereotactic body radiotherapy for stage I non–small cell lung cancer: A cost-effectiveness analysis
    Journal Article

    Wu, X.; Uhlig, J.; Blasberg, J. D.; Gettinger, S. N.; Suh, R. D.; Solomon, S. B.; Kim, H. S.
    Journal of Vascular and Interventional Radiology (2022)

    Fulltext@MSK | Save
  • Results from 22 years of followup in the Göteborg randomized population-based prostate cancer screening trial
    Journal Article

    Frånlund, M.; Månsson, M.; Godtman, R. A.; Aus, G.; Holmberg, E.; Kollberg, K. S.; Lodding, P.; Pihl, C. G.; Stranne, J.; Lilja, H.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Generalizing an antibiotic recommendation algorithm for treatment of urinary tract infections to an urban academic medical center
    Editorial

    Yoon, G.; Matulewicz, R. S.; Major, V. J.
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Validation of the Memorial Sloan Kettering gastric cancer post-resection survival nomogram: Does it stand the test of time?
    Journal Article

    Nakauchi, M.; Court, C. M.; Tang, L. H.; Gönen, M.; Janjigian, Y. Y.; Maron, S. B.; Molena, D.; Coit, D. G.; Brennan, M. F.; Strong, V. E.
    Journal of the American College of Surgeons (2022)

    Fulltext@MSK | Save